Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

41.20
Delayed Data
As of 3:59pm ET
 -0.15 / -0.36%
Today’s Change
17.25
Today|||52-Week Range
50.05
+63.17%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close41.35
Today’s open41.60
Day’s range40.85 - 42.15
Volume332,555
Average volume (3 months)694,374
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)+528.57%
Earnings growth (this year)-40.62%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.87%
P/E ratio20.6
Price/Sales6.07
Price/Book10.78

Competitors

 Today’s
change
Today’s
% change
FOLDAmicus Therapeutics ...+0.21+1.45%
PRTAProthena Corporation...-0.43-0.71%
IRWDIronwood Pharmaceuti...-0.10-0.64%
HZNPHorizon Pharma PLC-0.32-2.30%
Data as of 4:00pm ET, 10/16/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$215.0M
Annual profit (last year)$91.2M
Net profit margin42.43%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
Chief Financial Officer &
Vice President
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts